In addition, CLBC patients with less aggressive characteristics such as lower histological grade, smaller tumor size, none or limited lymph node metastasis, or positive ER or PR status tended to be treated with BCS. The gene discussed is ESR1; the disease is metastatic malignant neoplasm in the lymph nodes.